Joseph McClellan
Fortune : 517 568 $ au 31/05/2026
Fortune : 517 568 $ au 31/05/2026
Joseph E.
McClellan is Chief Scientific Officer at Alvotech hf since 2019.
Dr. McClellan is Chief Operating Officer at Alvotech starting in 2025.
Formerly, Dr. McClellan was Global Head-Biosimilars Development & Medicine at Pfizer Inc. Education includes undergraduate studies at College of the Holy Cross (Massachusetts), a doctorate from the University of Florida, and an MBA from Northeastern University (China).
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ALVOTECH 0,05 % | 06/03/2026 | 154 038 ( 0,05 % ) | 517 568 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ALVOTECH | Directeur des opérations | 12/11/2025 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Directeur Technique/Scientifique/R&D | 01/10/2019 |
| Sociétés | Poste | Fin |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
College of the Holy Cross (Massachusetts)
College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Florida
University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University (China)
Northeastern University (China) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Alvotech
Alvotech BiotechnologyHealth Technology Develops biologic medicines | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national